Difference between revisions of "Neurofilament proteins"
m |
m |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
− | |||
− | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 48: | Line 46: | ||
| TG2 catalyze the formation of higher molecular mass crosslinked products | | TG2 catalyze the formation of higher molecular mass crosslinked products | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 11:48, 10 March 2015
Neurofilament proteins | |
---|---|
Substrate peptide name | Neurofilament proteins |
Synonyms | NF-L, NF-M, NF-H |
Determination type | In situ/In vitro |
Source | Homo sapiens |
Subcellular localization | Neuronal cytoskeleton |
Swissprot ID | P12036 |
Reactive glutamines | Not determined yet |
Reactive lysines | Not determined yet |
Substrate sequence | |
Structure | No available crystal structure |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:11154823 |
Notes | TG2 catalyze the formation of higher molecular mass crosslinked products |